Skip to main content
. 2023 Jul 14;49(6):1568–1578. doi: 10.1093/schbul/sbad103

Table 1.

Sociodemographic and Clinical Characteristics of Samples 1 and 2.

Sample 1 Sample 2
SCZ (N = 66) ASPD (N = 52) Test Statistic/P value ASPD (N = 26) Controls (N = 25) Test Statistic/P value
Age mean (SD) 32.0 (9.8) 32.8 (12.2) t = 0.36, P = .722 32.5 (8.4) 34.6 (10.7) t = 0.78, P = .442
Sex (male) 66 (100%) 52 (100%) FET, P = 1.000 26 (100%) 25 (100%) FET, P = 1.000
IQ, mean (SD) 87.8 (13.4)* 87.7 (16.0)* F = 0.006, P = .941 91.5 (9.0) NA
Time since first hospitalization in years, mean (SD) 9.8 (8.1) NA NA NA
ASPD (%) 18 (27.3 %) 52 (100%) X2= 16.5, P < .001 26 (100%) 0 (0%) FET, P < .001
Substance use disorder, (%) 51 (77.3%) 52 (100%) Χ2 = 11.6, P < .001 26 (100%) 0 (0%) FET, P < .001
Duration of substance use disorder in years, mean (SD) 17.6 (10.4)* 19.9 (11.9)* t = 1.05, P = .300 19.0 (9.2) NA
Number of comitted homicides, median (range) 0 (0–3) 1 (0–3)* FET, P = .002 0.5 (0–3) NA
Number of attempted homicides, median (range) 0 (0–9)* 0 (0–2)* FET, P = .321 0 (0–1) NA
PCL-R, mean (SD) NA NA 29.9 (5.2) NA
Mean global grey matter volume, ml (SD) 673.71 (60.8) 687.44 (79.6) t = 1.030, P = .306 633.01 (51.9) 679.68 (65.0) t = 2.8, P = .007
Mean global white matter volume, ml (SD) 568.71 (52.5) 568.00 (67.7) t = −0.063, P = .950 610.18 (58.1) 630.68 (54.6) t = 1.3, P = .200

*Missing values.

FET, fisher exact test; NA, Not available.